Reply To: Is There a Kindling Effect in COPD Exacerbations?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Kwok W, Tam T, Chau C, Lam F, Man Ho J Lung. 2025; 203(1):37.
PMID: 40016611 PMC: 11868221. DOI: 10.1007/s00408-025-00792-9.
Εosinophilic Chronic Obstructive Pulmonary Disease. What Do We Know So Far?.
Bartziokas K, Papaioannou A, Rovina N, Papaiakovou G, Loukides S, Steiropoulos P Pulm Ther. 2024; 11(1):7-24.
PMID: 39661227 PMC: 11861475. DOI: 10.1007/s41030-024-00280-0.
References
1.
Reilev M, Lykkegaard J, Halling A, Vestbo J, Sondergaard J, Pottegard A
. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study. NPJ Prim Care Respir Med. 2017; 27(1):25.
PMC: 5435093.
DOI: 10.1038/s41533-017-0029-7.
View
2.
Agusti A, Celli B, Criner G, Halpin D, Anzueto A, Barnes P
. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023; 61(4).
PMC: 10066569.
DOI: 10.1183/13993003.00239-2023.
View
3.
Kardos P, Vogelmeier C, Worth H, Buhl R, Lossi N, Mailander C
. A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study. Respir Med. 2017; 124:57-64.
DOI: 10.1016/j.rmed.2017.02.007.
View
4.
Halpin D, Healey H, Skinner D, Carter V, Pullen R, Price D
. Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations. Eur Respir J. 2024; 64(4).
PMC: 11447287.
DOI: 10.1183/13993003.02240-2023.
View
5.
Higham A, Beech A, Singh D
. The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes. J Leukoc Biol. 2024; 116(5):927-946.
DOI: 10.1093/jleuko/qiae153.
View